Skip to main content
NAUT logo

NAUT · Nautilus Biotechnology, Inc. · Analyst Estimates

Track NAUT — free
$1.57 +0.15 (+10.56%) At close · Oct 1
Market Cap
$122.51M
Shares
127.26M
Volume · Oct 1 8.51M Avg daily vol (3M) 1.59M

Analyst Estimates

Compare analyst forecasts for Nautilus Biotechnology, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-30 13:25 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.53
-0.5125
-0.48
—
-0.505
-0.505
-0.51
-0.515
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
500000
536250
645000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.63
-0.5225
-0.41
—
-0.52
-0.52
-0.52
-0.52
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
3942000
5160500
7400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.15
-0.14333
-0.14
—
-0.15
-0.15
-0.145
-0.15
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
200000
206250
225000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.15
-0.13667
-0.11
—
-0.11
-0.11
-0.13
-0.11
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
200000
207500
230000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —
Key facts CIK 1808805 CUSIP 63909J108 13F (30d) 2 filings 2 filers Visit website Investor relations